Kin-Cohort Analysis of LRRK2-G2019S Penetrance in Parkinson's Disease
June 2011
in “
Movement Disorders
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide →
Studysummary The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer